Yoko Kojima Selected Research

Yoko Kojima Research Topics

Disease

12	Atherosclerosis 01/2022 - 06/2003
8	Inflammation (Inflammations) 01/2022 - 08/2007
4	Neoplasms (Cancer) 01/2022 - 01/2012
4	Aneurysm (Aneurysms) 01/2018 - 10/2008
3	Atherosclerotic Plaque (Atheroma) 01/2020 - 03/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 07/2010
3	HIV Infections (HIV Infection) 01/2018 - 07/2009
3	Lung Neoplasms (Lung Cancer) 08/2016 - 01/2012
3	Adenocarcinoma of Lung 08/2016 - 01/2016
3	Infections 10/2010 - 01/2007
2	Stroke (Strokes) 12/2021 - 06/2005
2	Malignant Mesothelioma 01/2021 - 01/2012
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 07/2007
2	Adenocarcinoma 08/2016 - 05/2010
2	Carcinogenesis 07/2016 - 01/2012
2	Neointima 12/2014 - 07/2010
2	Vascular Remodeling 12/2014 - 10/2008
2	Abdominal Aortic Aneurysm 05/2009 - 10/2008
2	Vascular Diseases (Vascular Disease) 10/2008 - 06/2005
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Rupture 12/2020
1	Carcinoma (Carcinomatosis) 08/2016
1	Lymphatic Metastasis 01/2016
1	Pathologic Constriction (Stenosis) 12/2014
1	Peripheral Arterial Disease 02/2014
1	Pulmonary Arterial Hypertension 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Mesothelioma 01/2012
1	Asbestosis 01/2012
1	Fibrosis (Cirrhosis) 01/2012
1	Silicosis 01/2012
1	Hypertriglyceridemia 08/2009
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2009
1	Diabetic Angiopathies (Diabetic Angiopathy) 05/2009
1	Aortic Aneurysm (Aneurysm, Aortic) 05/2009
1	Hypoalbuminemia 01/2008
1	Communicable Diseases (Infectious Diseases) 07/2007
1	Hypertension (High Blood Pressure) 06/2005

Drug/Important Bio-Agent (IBA)

5	Lipase (Acid Lipase)FDA Link 08/2009 - 10/2004
4	ApelinIBA 01/2013 - 10/2008
3	Apolipoproteins E (ApoE)IBA 01/2022 - 10/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 08/2016 - 03/2014
2	AsbestosIBA 01/2021 - 01/2012
2	LipidsIBA 12/2020 - 03/2014
2	ApolipoproteinsIBA 01/2020 - 10/2004
2	Cyclin-Dependent Kinase Inhibitor p15IBA 01/2019 - 03/2014
2	AntibodiesIBA 01/2018 - 01/2016
2	LigandsIBA 01/2017 - 03/2014
2	Pharmaceutical PreparationsIBA 10/2010 - 07/2007
2	HDL CholesterolIBA 08/2009 - 01/2008
2	N-acetyltalosaminuronic acid (NAT)IBA 07/2009 - 01/2007
2	oxidized low density lipoproteinIBA 05/2009 - 08/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Galectin 3 (LGALS3)IBA 01/2021
1	MesothelinIBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Secretory Leukocyte Peptidase InhibitorIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	ChemokinesIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	CholesterolIBA 01/2020
1	CytokinesIBA 01/2020
1	AnaphylatoxinsIBA 01/2020
1	resolvin D1IBA 01/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	TropomyosinIBA 08/2016
1	Cathepsin LIBA 07/2016
1	ElementsIBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2014
1	CalreticulinIBA 03/2014
1	Antiviral Agents (Antivirals)IBA 07/2013
1	Oxygen (Dioxygen)IBA 01/2012
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2012
1	NitrogenIBA 01/2012
1	LipopolysaccharidesIBA 01/2011
1	pitavastatin (itavastatin)FDA Link 07/2010
1	Apelin ReceptorsIBA 07/2010
1	Phenobarbital (Luminal)FDA Link 07/2010
1	Bromodeoxyuridine (BrdU)IBA 07/2010
1	Biological ProductsIBA 05/2010
1	Triglycerides (Triacylglycerol)IBA 08/2009
1	Nucleic AcidsIBA 07/2009
1	HIV AntibodiesIBA 07/2009
1	Receptor for Advanced Glycation End ProductsIBA 05/2009
1	LDL Receptors (LDL Receptor)IBA 05/2009
1	Pancreatic Elastase (Elastase)IBA 05/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2008
1	Ribonucleases (Ribonuclease)IBA 06/2005
1	Messenger RNA (mRNA)IBA 06/2005
1	Proteoglycans (Proteoglycan)IBA 06/2003

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2018
1	Stents 12/2014
1	Ligation 07/2010